Back to News

CIO Review Names TikaMobile Top 10 in Life Science Technology Vendors

New York, NY (May 2019)— CIO Review, a leading magazine in enterprise tech, named TikaMobile Inc. as a top 10 vendor for life science technology. Tika’s cutting-edge software has earned this reputable distinction for its data-driven and immersive application for pharmaceutical and medical device companies.

To be named among the top 10 is tremendously exciting for TikaMobile, a cloud-based analytics CRM software provider for the life sciences industry. Tika’s ability to embed business intelligence into the CRM platform creates a powerful shift in advanced data accessibility for sales reps, pushing the boundaries in comparison to legacy CRMs.

Following Tika’s recognition, CIO sat down with TikaMobile’s founder and CEO, Manish Sharma to  inquire further about TikaMobile’s evolution in the business.

“We have expanded our product line on the pharmaceutical side significantly by bringing tools for medical science liaisons and market access teams,” Sharma tells CIO Review. “It is hard to thank CIO enough for granting us this accolade, and we are honored to be featured. We are excited for the expansion of our product line and the ability to adapt with the life science industry,” Sharma states.

Tika plans to introduce data lakes, artificial intelligence, machine learning technology to their next generation of innovative solutions.

To explore more about TikaMobile and what we have to offer, click here or email info@tikamobile.com.

To read other articles from CIO Review, click here

May 1, 2019

You might also like

April 17, 2026

AI in Medical Affairs: A Practical Guide to KOL Engagement and MSL Efficiency

Your Medical Affairs team is drowning in signal. Publications, trial readouts, congress content, real-world evidence, digital discourse, MSL field notes — every channel is producing more data,.

April 1, 2026

Commercial Analytics in Pharma and Life Sciences: The Complete Guide for 2026

Commercial Analytics in Pharma and Life Sciences: The Complete Guide for 2026 The pharmaceutical industry stands at a pivotal crossroads. With R&D costs continuing to climb and nearly 50% of drug.

March 26, 2026

Omnichannel KOL Engagement Strategy: A 2026 Playbook for Pharma Field Teams

Omnichannel KOL Engagement Strategy: A 2026 Playbook for Pharma Field Teams Most pharma companies have an omnichannel KOL engagement strategy on paper. Few have one that their MSLs actually use. The.